Danaher Corporation (BMV:DHR)
Mexico · Delayed Price · Currency is MXN 3,670.00
-88.00 (-2.34%)
At close: Aug 1, 2025, 2:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Former Life Sciences | - | Log In | Log In | Log In | Log In | Upgrade |
Former Life Sciences Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics | 9.79B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Growth | 0.01% | Log In | Log In | Log In | Log In | Upgrade |
Environmental & Applied Solutions | - | Log In | Log In | Log In | Log In | Upgrade |
Environmental & Applied Solutions Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Biotechnology | 6.76B | Log In | Log In | Log In | Log In | Upgrade |
Biotechnology Growth | 4.86% | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences | 7.33B | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences Growth | 1.68% | Log In | Log In | Log In | Log In | Upgrade |
Recurring | 19.37B | Log In | Log In | Log In | Log In | Upgrade |
Recurring Growth | 4.02% | Log In | Log In | Log In | Log In | Upgrade |
Non-Recurring | 4.51B | Log In | Log In | Log In | Log In | Upgrade |
Non-Recurring Growth | -6.76% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | -35.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Former Life Sciences Operating Income | - | Log In | Log In | Log In | Log In | Upgrade |
Former Life Sciences Operating Income Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Operating Income | 2.63B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Operating Income Growth | -6.69% | Log In | Log In | Log In | Log In | Upgrade |
Environmental & Applied Solutions Operating Income | - | Log In | Log In | Log In | Log In | Upgrade |
Environmental & Applied Solutions Operating Income Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | -35.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Biotechnology Operating Income | 1.69B | Log In | Log In | Log In | Log In | Upgrade |
Biotechnology Operating Income Growth | 15.43% | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences Operating Income | 879.00M | Log In | Log In | Log In | Log In | Upgrade |
Life Sciences Operating Income Growth | -63.29% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
North America | 10.30B | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | 0.22% | Log In | Log In | Log In | Log In | Upgrade |
Western Europe | 5.46B | Log In | Log In | Log In | Log In | Upgrade |
Western Europe Growth | 7.70% | Log In | Log In | Log In | Log In | Upgrade |
Other Developed Markets | 1.25B | Log In | Log In | Log In | Log In | Upgrade |
Other Developed Markets Growth | -1.20% | Log In | Log In | Log In | Log In | Upgrade |
High-Growth Markets | 6870000000.00% | Log In | Log In | Log In | Log In | Upgrade |
High-Growth Markets Growth | 0.48% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Core Sales Growth | -1.50% | Log In | Log In | Log In | Log In | Upgrade |
Core Sales Growth Ex-Cytiva | - | Log In | Log In | Log In | Log In | Upgrade |